Benjamin Otto

WORK HISTORY

EDUCATION

SKILLS

ABOUT BENJAMIN OTTO

Senior product & innovation manager and proven leader, driving corporate strategic projects and product strategies with a combined 18 years of experience in life science, personalized medicine & diagnostics, high-throughput workflows and biobanking. An inter-professional team player and team leader to bridge the gaps between the professions and boost communication by translating from Medical language to IT-speak to Business-mindset. & : Leadership, Business Management (MBA), Innovation, Strategy Development and Execution, Early cancer detection, Liquid Biopsies & Clinical Diagnostics (member at German DGKL), biobanking (Member at ISBER), NGS, Omics & Bioinformatics (German Venia Legendi) and hands-on lab work experience: Management of a double digit million product portfolio at Eppendorf including product & marketing strategy development, R&D lead and communication towards marketing, production & logistics. MyArea (http://my-area.eu) a light CRM system aiming to empower the sales force to focus on what they are best at - selling. Certainly not the last startup, hopefully the only failed one. but wish I had founded Motryx is based on a clinical quality control procedure we developed at the UKE (see Cover Article ClinChem1390 and the corresponding podcast at The system is now being adopted by multiple labs globally thanks to the phenomenal work of @Franziska et al.(Motryx). Thank you Fran for awaking it to life, you have made it better than we would ever have been able to! & Corporate wide introduction of Global Trade Item Numbers (GTINs) at Eppendorf. Eppendorf compliance with EU IVD-R Unique Device Identification (UDI) requirements incl. background processes. Both as project lead. Co-Chair of ISBER 2021 Annual Meeting, Member of ISBER Member Relations committee, setup from scratch of a Liver disease Biobank including all processes and data privacy issue environment. Heading core facility for high throughput analysis (Microarray analysis and NGS). Across the aisle medical research projects with special focus on bioinformatic prediction models for early cancer detection and subtyping (see amongst others our back-2-back Articles (IJC27783/IJC27941).